[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"immunoparalysis-in-septic-shock\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:immunoparalysis-in-septic-shock":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100622823",false,"NCT07388628","ARTICE® Real Data Collection & Observational Trial, Phase 4 Study","ARTISTRY - ARTICE® Therapy Registry Study","ARTistry","Inclusion Criteria:\n\n* Subjects ≥ 18 years who are planned to receive ARTICE® treatment during their ICU stay\n\nExclusion Criteria:\n\n\\-","ALL","18 Years",{"count":19,"type":20},200,"ESTIMATED","7 Days","OBSERVATIONAL","The objectives of this registry study are to:\n\n1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects.\n2. Further evaluate ARTICE® treatment efficacy.\n3. Identify potential sub-groups, assess their risk-benefit- and safety profile.\n4. Changes in SOFA score D0 to SOFA Score D7.",[25,26,27],"Sepsis","Septic Shock","Immunoparalysis in Septic Shock",[25,29,27],"septic shock","RECRUITING","2026-02-06",{"date":33,"type":34},"2026-02-09","ACTUAL",{"date":36,"type":34},"2025-09-25",{"date":38,"type":20},"2027-12",{"name":40,"class":41},"Artcline GmbH","INDUSTRY",""]